Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
136.70
+2.31 (1.72%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Palvella Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Market Capitalization | 1,837 | 135 | - | - |
| Enterprise Value | 1,789 | 215 | - | - |
| Last Close Price | 136.70 | 12.00 | - | - |
| PB Ratio | 39.19 | 2.15 | - | - |
| P/TBV Ratio | 47.48 | 2.15 | - | - |
| Debt / Equity Ratio | 0.41 | 0.19 | -2.08 | -1.40 |
| Net Debt / Equity Ratio | -1.23 | -1.14 | -0.18 | -0.71 |
| Quick Ratio | 6.38 | 7.14 | 3.11 | 2.78 |
| Current Ratio | 6.49 | 7.33 | 3.20 | 2.86 |
| Return on Equity (ROE) | -301.19% | -59.37% | - | - |
| Return on Assets (ROA) | -47.54% | -18.39% | -61.63% | - |
| Return on Capital Employed (ROCE) | -55.90% | -18.50% | -228.80% | -167.90% |
| Earnings Yield | -1.76% | -12.95% | - | - |
| Buyback Yield / Dilution | -60.51% | -24.08% | 68.63% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.